Literature DB >> 17666559

The effects of hypoxia on the cells of the pulmonary vasculature.

O Pak1, A Aldashev, D Welsh, A Peacock.   

Abstract

Pulmonary hypertension is associated with remodelling of pulmonary vessels. Chronic hypoxia is a common cause of pulmonary hypertension and pulmonary vascular remodelling. Vascular remodelling is characterised largely by fibroblast, smooth muscle and endothelial cell proliferation, which results in lumen obliteration. Chronic hypoxia elicits expression of mitogens, growth factors and cytokines by fibroblasts and endothelial cells, and also the suppression of endothelial nitric oxide synthase. Although hypoxic pulmonary vascular remodelling is associated with medial hypertrophy, many in vitro studies have found that hypoxia does not lead to a direct increase in smooth muscle cell proliferation. This paradox is not well understood and this review aims to examine the various reasons why this might be so. The present authors reviewed data from in vitro studies and also considered whether hypoxia could act on adjacent cells such as fibroblasts and endothelial cells to trigger smooth muscle cell proliferation. It is possible that hypoxia is sensed by fibroblasts, endothelial cells, or both, and relayed to adjacent pulmonary artery smooth muscle cells by intercellular signalling, causing proliferation. The present article reviews the data from in vitro studies of hypoxia on the three cellular components of the pulmonary vascular wall, namely endothelial cells, smooth muscle cells and fibroblasts.

Entities:  

Mesh:

Year:  2007        PMID: 17666559     DOI: 10.1183/09031936.00128706

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  72 in total

1.  Vascular morphogenesis of adipose-derived stem cells is mediated by heterotypic cell-cell interactions.

Authors:  Daphne L Hutton; Elizabeth A Logsdon; Erika M Moore; Feilim Mac Gabhann; Jeffrey M Gimble; Warren L Grayson
Journal:  Tissue Eng Part A       Date:  2012-05-09       Impact factor: 3.845

2.  Inhibition of MRP4 prevents and reverses pulmonary hypertension in mice.

Authors:  Yannis Hara; Yassine Sassi; Christelle Guibert; Natacha Gambaryan; Peter Dorfmüller; Saadia Eddahibi; Anne-Marie Lompré; Marc Humbert; Jean-Sébastien Hulot
Journal:  J Clin Invest       Date:  2011-06-13       Impact factor: 14.808

3.  17β-Estradiol attenuates hypoxic pulmonary hypertension via estrogen receptor-mediated effects.

Authors:  Tim Lahm; Marjorie Albrecht; Amanda J Fisher; Mona Selej; Neel G Patel; Jordan A Brown; Matthew J Justice; M Beth Brown; Mary Van Demark; Kevin M Trulock; Dino Dieudonne; Jagadeshwar G Reddy; Robert G Presson; Irina Petrache
Journal:  Am J Respir Crit Care Med       Date:  2012-03-01       Impact factor: 21.405

4.  Iptakalim ameliorates hypoxia-impaired human endothelial colony-forming cells proliferation, migration, and angiogenesis via Akt/eNOS pathways.

Authors:  Mengyu He; Ting Cui; Qing Cai; Hong Wang; Hui Kong; Weiping Xie
Journal:  Pulm Circ       Date:  2019-10-18       Impact factor: 3.017

5.  Hypoxia-induced pulmonary arterial smooth muscle cell proliferation is controlled by forkhead box M1.

Authors:  Aarti Raghavan; Guofei Zhou; Qiyuan Zhou; Joyce Christina F Ibe; Ramaswamy Ramchandran; Qiwei Yang; Harini Racherla; Pradip Raychaudhuri; J Usha Raj
Journal:  Am J Respir Cell Mol Biol       Date:  2011-10-27       Impact factor: 6.914

6.  Overview on Interactive Role of Inflammation, Reactive Oxygen Species, and Calcium Signaling in Asthma, COPD, and Pulmonary Hypertension.

Authors:  Lillian Truong; Yun-Min Zheng; Sharath Kandhi; Yong-Xiao Wang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Macrophage migration inhibitory factor mediates hypoxia-induced pulmonary hypertension.

Authors:  Yinzhong Zhang; Arunabh Talwar; Donna Tsang; Annette Bruchfeld; Ali Sadoughi; Maowen Hu; Kennedy Omonuwa; Kai Fan Cheng; Yousef Al-Abed; Edmund J Miller
Journal:  Mol Med       Date:  2012-03-27       Impact factor: 6.354

8.  Differential regulation of pulmonary vascular cell growth by hypoxia-inducible transcription factor-1α and hypoxia-inducible transcription factor-2α.

Authors:  Aftab Ahmad; Shama Ahmad; Kenneth C Malcolm; Stacy M Miller; Tara Hendry-Hofer; Jerome B Schaack; Carl W White
Journal:  Am J Respir Cell Mol Biol       Date:  2013-07       Impact factor: 6.914

Review 9.  Molecular mechanisms of hypoxia-inducible factor-induced pulmonary arterial smooth muscle cell alterations in pulmonary hypertension.

Authors:  Christine Veith; Ralph T Schermuly; Ralf P Brandes; Norbert Weissmann
Journal:  J Physiol       Date:  2015-09-30       Impact factor: 5.182

10.  Hypoxia-induced endothelial CX3CL1 triggers lung smooth muscle cell phenotypic switching and proliferative expansion.

Authors:  Jianliang Zhang; Hanbo Hu; Nadia L Palma; Jeffrey K Harrison; Kamal K Mubarak; Robin D Carrie; Hassan Alnuaimat; Xiaoqiang Shen; Defang Luo; Jawaharlal M Patel
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-09-21       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.